Increased CD80(+) B Cells in Active Multiple Sclerosis and Reversal by Interferon Beta-1b Therapy.

Journal of Clinical Investigation - United States
doi 10.1172/jci119455
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

T-Cell Interferon Gamma Receptor Binding in Interferon Beta-1b–Treated Patients With Multiple Sclerosis

Archives of Neurology
1999English

Autoimmune Hypothyroidism Associated With Interferon Beta-1b Treatment in Two Patients With Multiple Sclerosis

Australian and New Zealand Journal of Medicine
2000English

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis
Neurology
2011English

Alternative Statistical Methods for Estimating Efficacy of Interferon Beta-1b for Multiple Sclerosis Clinical Trials

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2011English

Multiple Sclerosis-Linked and Interferon-Beta-Regulated Gene Expression in Plasmacytoid Dendritic Cells

Journal of Neuroimmunology
AllergyImmunologyNeurology
2012English

Treatment Recommendations for Interferon-Beta in Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1999English

Erythema Elevatum Et Diutinum, Multiple Sclerosis and Interferon Beta

Dermatology
Dermatology
2004English

B Cells in Multiple Sclerosis

Autoimmunity
AllergyImmunology
2017English

Fludarabine Add-On Therapy in Interferon-Beta-Treated Patients With Multiple Sclerosis Experiencing Breakthrough Disease

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy